The Lung Institute Takes on the Future of Stem Cells

The Lung Institute is a national leader in stem-cell treatments for diseases of the lung, such as COPD, pulmonary fibrosis, and emphysema. With locations in five cities, the institute specializes in helping to improve the quality of life for people afflicted with these types of health issues. According to the Baylor College of Medicine and Lung Institute’s internal research, more than 84% of those who sought therapy for COPD with the institute experienced improved quality of life.

Chronic lung diseases are notoriously difficult to treat. The Lung Institute has pioneered a number of techniques employing stem cells and plasma transplantation to regenerate tissue that has been gradually damaged over the years. Stem cell treatments rely on a property called plasticity, meaning the ability of cells from one part of the body to carry on the same function in another part of the body. The type of stem-cell treatments that the Lung Institute uses only use the patient’s own stem cells, not those of others.

Lung Institute physicians are active at international medical conferences and are highly regarded as experts in this nascent field. Dr. Jack Coleman recently gave a presentation at a conference in Padua, Italy, in which he outlined recent developments in regenerative treatments and his view of the potential these techniques have for the future. Dr. Coleman’s lecture was critical of the status quo in developing new treatment modalities. In Coleman’s view, the current system is too slow and non-responsive, and he hopes the United States and other countries will adopt new practices drawing on the examples of other countries which have streamlined these processes.

To read more, go to

Lung Institute’s Twitter: